相关实验视频
Updated: May 5, 2026
14:56
Remote Laboratory Management: Respiratory Virus Diagnostics
Published on: April 6, 2019
33.1K
IVDCheckR - 通过引入新的数字工具来简化实验室根据IVDR要求开发的测试文件
Yadwinder Kaur1, Daniel Rosenkranz1, Anna Bloemer1
1Institute for Clinical Chemistry and Laboratory Medicine, University Medicine Oldenburg, Oldenburg, Germany.
Clinical chemistry and laboratory medicine
|August 28, 2024
概括
临床实验室面临的挑战是,对于经过修改的CE标记测试和实验室开发的测试 (LDT) 的体外诊断医疗器械条例 (IVDR). 一个新的R Shiny网络工具,IVDRCheckR,简化了LDT文档和测试修改的IVDR合规性.
科学领域:
- 临床诊断和监管合规性
- 在体外诊断 (IVD) 和医疗器械法规.
- 实验室开发的测试 (LDTs) 和测试验证测试.
背景情况:
- 临床实验室在遵守CE标记的体外诊断医疗器械 (IVD) 显著修改指南时遇到困难.
- 关于IVD (IVDR) 的修订条例 (EU) 2017/746即将实施,对于使用实验室开发的测试 (LDT) 的诊断公司和临床实验室来说都带来了挑战.
- 缺乏精简的框架使得对LDT文档和处理试验修改的IVDR要求的满足变得更加复杂.
研究的目的:
- 引入一个数字工具,帮助临床实验室实施LDT的IVDR要求.
- 为 CE 标记 IVD 的重大修改提供透明和有效处理的解决方案.
- 在IVDR框架下简化LDT的文档化过程.
主要方法:
- 使用R Shiny网络应用程序开发基于Web的数字工具.
- 专注于促进对LDTs的IVDR要求的实施.
- 该工具解决了对CE标记的IVD进行重大修改的适当处理.
主要成果:
- 介绍了IVDRCheckR,这是一个开源,可访问和无依赖的网络工具.
- 该工具提高了从LDT中获得的实验室检查结果的透明度,可靠性和有效性.
- IVDRCheckR包括用于评估质量控制和量化方法比较数据的模块.
结论:
- 开发的Shiny网络应用程序为LDT文档提供了一个数字化,用户友好的平台.
- 该工具专门解决了在IVDR框架内处理CE标记测试修改的复杂性.
- 它简化了合规性,并加强了LDT的整体质量管理.
相关概念视频
01:30Methods of Documentation VII: EMR
1.6K
Electronic Medical Records (EMRs) primarily center around electronically documenting patients' health information within a single healthcare organization or practice. They contain essential clinical data related to a patient's medical history, diagnoses, medications, treatment plans, lab results, and other pertinent information relevant to the specific encounter or episode of care. EMRs are designed to streamline documentation and workflow processes within individual healthcare...
1.6K
01:10In Vitro Drug Release Testing: Overview, Development and Validation
600
In vitro dissolution and drug release tests assess how quickly and how much of a drug is released from its dosage form into an aqueous medium under standardized laboratory conditions. These tests are essential tools in pharmaceutical development and quality assurance, offering insight into the drug's performance before clinical use.During formulation development, dissolution testing identifies incomplete or inconsistent drug release issues. It also supports decisions on selecting the optimal...
600
01:20Drug Product Performance: In Vitro–In Vivo Correlation
439
In pharmaceutical development, it's crucial to establish a predictive in vitro–in vivo correlation (IVIVC) for two or more formulations to gain a comprehensive understanding of release properties. IVIVC reduces the need for costly in vivo studies and facilitates the establishment of meaningful dissolution specifications with significant cost savings and decreased regulatory burden. Furthermore, a meaningful IVIVC should predict Cmax and AUC within 20%, aligning with FDA guidance while...
439
01:29Clinically Relevant Drug Product Specifications: Methods of Establishment
303
Product specifications define the acceptable quality of a pharmaceutical product by ensuring identity, purity, potency, and strength. These specifications serve as benchmarks during development, manufacturing, and post-approval quality control. Clinically relevant specifications are particularly important because they directly relate to a drug's safety and efficacy in clinical use.Dissolution studies are critical biopharmaceutic tools that link in vitro behavior to in vivo performance. They...
303
01:24Automated Microbial Diagnostics
79
Automated diagnostic analyzers have transformed clinical microbiology by providing rapid and reliable methods for pathogen identification and antibiotic susceptibility testing. Among these systems, the Vitek 2 is widely used because it automates the traditionally labor-intensive processes of microbial identification (ID) and antibiotic susceptibility testing (AST), delivering standardized and timely results that are essential for effective patient care.Microbial Identification with ID CardsThe...
79